SCHEMBL3637945

SCHEMBL3637945

CCOC(=O)CCCn1c(=O)n(C2CCN(C(=O)O)CC2)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CACNA1G O43497 3/20 0.57
▸ CACNA1H O95180 3/20 0.57
▸ OPRM1 P35372 2/20 0.55
▸ TACR1 P25103 1/20 0.55
▸ TNF P01375 1/20 0.51
▸ CYP3A4 P08684 4/20 0.51
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ CYP2D6 P10635 3/20 0.46
▸ C5AR1 P21730 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ CHRM4 P08173 1/20 0.44
▸ CHRM5 P08912 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ CHRM3 P20309 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ OPRL1 P41146 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3633277 0.82 CACNA1G (0.50) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL3752436 0.82 CACNA1G (0.50) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4804451 0.77 CACNA1G (0.43) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4804471 0.77 CACNA1G (0.43) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4804476 0.77 CACNA1G (0.43) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4804462 0.77 CACNA1G (0.43) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4683069 0.76 CYP2D6 (0.66) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1
SCHEMBL8111309 0.75 ALDH1A1 (0.57) OPRM1TACR1ALDH1A1KDM4EL3MBTL1
SCHEMBL10831250 0.74 TNF (0.60) TNFALDH1A1KDM4EL3MBTL1GAA
Oxalic Acid SCHEMBL5778359 0.74 CACNA1G (0.68) CACNA1GCACNA1HOPRM1TACR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP claimed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO claimed
EP-1997805-A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans Commissariat à l'Energie Atomique (FR) 2008-12-03 — — EP claimed
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback